Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials. [electronic resource]
Producer: 20060912Description: 3871-9 p. digitalISSN:- 1527-7755
- Adult
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carmustine -- administration & dosage
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Disease-Free Survival
- Female
- Glioblastoma -- drug therapy
- Humans
- Male
- Middle Aged
- Prognosis
- Radiotherapy, Adjuvant
- Survival Analysis
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.